
|Articles|June 1, 2002
Moxifloxacin: a once-daily, fourth-generation fluoroquinolone antibiotic
Product Profile
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
PBM reform. It has finally happened
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
ACHP announces new funding to elevate patient voices in diabetes research
4
Melanoma diagnoses projected to rise in 2026
5























